Research Beam added a report on “Female Sexual Dysfunction Global Clinical Trials Review, H2, 2015”
Enquiry about report: http://www.researchbeam.com/female-sexual-dysfunction-global-clinical-trials-review-h2-2015-market/enquire-about-report
2. Report Overview
Female Sexual Dysfunction Global Clinical Trials Review, H2, 2015 provides an overview of Female Sexual
Dysfunction clinical trials scenario. This report provides top line data relating to the clinical trials on
Female Sexual Dysfunction. Report includes an overview of trial numbers and their average enrollment in
top countries conducted across the globe. The report offers coverage of disease clinical trials by region,
country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent
drugs for in-progress trials (based on number of ongoing trials).
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial
Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining
to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason
for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
Read More At: http://www.researchbeam.com/female-sexual-dysfunction-global-clinical-trials-review-
h2-2015-market
3. Table of Content
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Female Sexual Dysfunction to Women's Health Clinical Trials
15
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Female Sexual Dysfunction to Women's Health Clinical Trials
19
Clinical Trials by Phase in E7 Countries 21
Clinical Trials in E7 Countries by Trial Status 22
Clinical Trials by Phase 23
In Progress Trials by Phase 24
4. Table of Content
Clinical Trials by Trial Status 25
Clinical Trials by End Point Status 27
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Female Sexual Dysfunction Therapeutics Clinical Trials 32
Prominent Drugs 34
Latest Clinical Trials News on Female Sexual Dysfunction 35
Oct 28, 2015: Strategic Science and Technologies Initiates Phase 2 Study to Evaluate Topical Sildenafil in
Women with Female Sexual Arousal Disorder 35
Clinical Trial Profile Snapshots 36
Appendix 146
Abbreviations 146
Definitions 146
Research Methodology 147
Secondary Research 147
About GlobalData 148
Contact Us 148
Disclaimer 148
Source 149
Enquire At : http://www.researchbeam.com/female-sexual-dysfunction-global-clinical-trials-review-h2-
2015-market/enquire-about-report
5. FOR MORE DETAILS
Visit us at :
Stay With Us:
http://www.researchbeam.com/female-sexual-dysfunction-global-clinical-trials-review-h2-2015-
market
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
United States
TELEPHONE: +1 (800) 910-6452
DIRECT: +1 (503) 894-6022
E-MAIL: sales@researchbeam.com